CBD-Microglia PET Study
Effect of Cannabidiol on Microglial Activation and Central Pain-Sensitization
This study is testing if a special brain scan can help us understand how CBD affects immune cells in the brain for people with certain conditions.
Quick facts
| Phase | Early Phase 1 |
|---|---|
| Study type | Interventional |
| Enrollment | 15 (estimated) |
| Ages | 18 Years to 55 Years |
| Sex | All |
| Sponsor | Yale University Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (New Haven, Connecticut) |
| Trial ID | NCT04398719 on ClinicalTrials.gov |
What this trial studies
Processing failed - manual review needed
Who should consider this trial
Good fit: Unknown
Not a fit: Unknown
Why it matters
Potential benefit: Unknown
How similar studies have performed: Unknown
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Men and women aged 18- 55 years 2. No significant medical or neurological illness 3. No implanted metal devices that may pose a risk during MRI scanning 4. Within the annual permissible radiation exposure 5. Able to provide written informed consent. Exclusion Criteria: 1. Current use of any medications 2. Presence of metal in the body 3. Pregnancy or lactation
Where this trial is running
New Haven, Connecticut
- Connecticut Mental Health Center — New Haven, Connecticut, United States (Recruiting)
Study contacts
- Principal investigator: Rajiv Radhakrishnan, MD — Yale University
- Study coordinator: Rajiv Radhakrishnan, MD
- Email: rajiv.radhakrishnan@yale.edu
- Phone: 203-974-7489
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-06-09 by the Find a Trial editorial team.
Information on this page is for educational purposes and is not medical advice.
Always consult qualified healthcare professionals about clinical trial participation.